483 Bayer Healthcare Pharmaceuticals May 2013

483 Bayer Healthcare Pharmaceuticals May 2013

Lynda Perry FDA, Daniel Roberts FDA, Rebecca Rodriguez FDA$119.00 - Available Now

FDA investigators audited the Bayer Healthcare Pharmaceuticals - Emeryville, CA, United States facility and issued 4 inspectional observations (via FDA 483) on 24 May 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 4
  • Inspection end: 24 May 2013
  • Location: Emeryville, United States
  • FEI: 3006481922
Add To Cart